In Entwicklung
Business·22.6.2026KI-Zusammenfassung
UPS Invests $48 Million in Temperature-Controlled Facilities for Weight-Loss Drugs
UPS is investing $48 million in 27 temperature-controlled facilities globally to meet the rising demand for GLP-1 weight-loss drugs and other sensitive medications, ensuring they remain within required temperature ranges for patient use.
T
The Independent World3 Min. Lesezeit
